Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 390 results for "sun pharma advanced research"

SPARC up 1%; RIC extends closure of issue until April 13
India Infoline

Sun Pharma Advanced board nod to rights issue allotment

Sun Pharma Advanced Research Company has informed the exchanges that the rights issue committee on Wednesday approved the allotment of 1.02 crore fully paid-up equity shares at ₹245 an equity share on... Business Line, 1 week ago
Hold Sun Pharma Advanced, says Sandeep Wagle Money Control, 3 weeks ago
Business Today India

SPARC board approves Rs 250 crore rights issue

Sun Pharma Advanced Research Company (SPARC) said on Wednesday the rights issue committee of its board has approved raising over Rs 249.99 crore. Rights issue committee of director, authorised by board of directors, has approved the allotment of ...
 Business Today India1 week ago SPARC's Rs 250-crore rights issue to open on March 28  Economic Times1 month ago

Buy SPARC, Idea Cellular; sell UPL: Ashwani Gujral

Ashwani Gujral, of recommends buying Sun Pharma Advanced Research Company and Idea Cellular and advises selling UPL.
 Money Control1 week ago

Fortune Financial, Sun Pharma research to roll out rights issue on Monday

While Fortune Financial aims to raise Rs 204 crore, Sun Pharma Advanced Research Company plans to mop up Rs 250 crore from the rights issue.
 DNA1 month ago Rights issue of SPARC, FFSI to open tomorrow; aim to raise Rs 454 crore  Economic Times1 month ago Fortune Financial, SPARC rights issue opens on Monday  Business Line1 month ago Rights issue of 2 companies to open tomorrow; aim to raise Rs 454 cr  Smart Investor1 month ago
India Infoline

SUN PHARMA ADVANCED RESEARCH : SPARC to issue 1.02 cr equity shares at Rs.245/Sh via rights issue

Sun Pharma Advanced Research Company Ltd has approved the allotment of 1,02,04,081 fully paid-up equity shares of face value of Re. 1 each at a price of Rs. 245 per equity share (including a share premium of Rs. 244 per equity share) issued on a ...
 4 Traders1 week ago SPARC ends 2% higher; will allot 10.2 mn shares via rights issue  India Infoline1 week ago SPARC to issue 1.02 cr equity shares at Rs.245/Sh via rights issue  India Infoline1 week ago SPARC announces rights issue; ratio at 5 shares for every 116 shares  India Infoline1 month ago
Business Standard India

Sun Pharma to sell AstraZeneca's diabetes drug in India

A man carrying a gas cylinder walks out of the research and development centre of Sun Pharmaceutical Industries in Mumbai. Photo: Reuters Sun Pharmaceutical Industries and AstraZeneca India on Wednesday announced a partnership under which the ...
 Business Standard India1 month ago Pharmalot, Pharmalittle: Sanofi poaches a top scientist from AstraZeneca  StatNews.com1 month ago PharmaBoardroom Releases New Mauritius Pharmaceuticals Report  WorldNetDaily1 month ago

API Contract Manufacturing Market in Pharmaceutical Industry - 2020

A latest market report published by Transparency Market Research is Posted via Industry Today. Follow us on Twitter @IndustryToday A new market research report by Transparency Market Research presents a detailed analysis of the global API contract ...
 Industry Today1 month ago Global API Contract Manufacturing Market to Be Driven by Reducing Cost of Production  Digital Journal1 month ago
American Banking News - Earnings

Research Analysts Price Target Changes for March, 9th (AAAP, ACR.UN, AEI, AFH, AGEN, AHT, AKBA, ALNY, AMTD, ARDX)

Advanced Accelerator Application SA (NASDAQ:AAAP) had its target price cut by JMP Securities from $44.00 to $36.00. JMP Securities currently has a market outperform rating on the stock. Advanced Accelerator Application SA (NASDAQ:AAAP) had its ...
 American Banking News - Earnings1 month ago

Pharmaceutical Newsletter - April 25 to 29, 2016

Top News Delhi HC allows Biocon, Mylan to continue sale of Cancer drugs The Delhi High Court has allowed Biocon Ltd and Mylan Pharmaceuticals Pvt Ltd to continue manufacturing and marketing their breast cancer drug under brand names CANMAb and ...
 India Infoline5 days ago

Pharmaceutical Newsletter April 04 t

Top News Pfizer terminates US$ 160 bn merger with Allergan Pfizer Inc. today announced that the merger agreement between Pfizer and Allergan plc has been terminated by mutual agreement of the companies. Read more NPPA caps Hepatitis C drug's ...
 India Infoline3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharma advanced research
Get updated on latest news & your favorite topics right in your inbox!
More     Less